There were 312 press releases posted in the last 24 hours and 437,663 in the last 365 days.

Contact

Please use this form to send email to PR contact of this press release:
Celltrion USA announces submission of the Biologics License Application (BLA) of novel subcutaneous formulation of CT-P13 to U.S. Food and Drug Administration

TO:



FROM:

Please check your email address!

Please, do not fill this field.

Please, do not change this field.

Please, do not fill if your javascript is turned off.

captcha image